During the past decade, Advanced Clinical Research conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 63 clinical trials were completed, i.e. on average, 68.5% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 49 clinical trials were completed. i.e. 158.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Clinical Research" #1 sponsor was "Pfizer" with 17 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "Allergan" with 5 trials sponsored, "Takeda" with 5 trials sponsored and "ModernaTX, Inc." with 5 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Clinical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator and "Parexel" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research" are "Migraine" (9 trials), "ADHD" (5 trials), "Rheumatoid Arthritis" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials) and "Diabetes Mellitus, Type 1" (3 trials). Many other conditions were trialed in "Advanced Clinical Research" in a lesser frequency.

Most popular intervention types in "Advanced Clinical Research" are "Drug" (79 trials), "Biological" (33 trials), "Other" (10 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "Dihydroergotamine" (3 trials), "Galcanezumab" (3 trials), "Lasmiditan" (3 trials) and "200mg SPN-812" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Clinical Research" are 101 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 19 active trials in "Advanced Clinical Research". 1 are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 83 completed trials in Advanced Clinical Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Clinical Research, 7 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".